Skip to main content

Table 2 Comparison of treatment induced changes in both groups

From: High efficacy of low-dose albumin infusion in the prevention of paracentesis-induced circulatory dysfunction

 

Low-dose albumin

Standard-dose albumin

p

N = 85

N = 25

Δ Weight, kg

− 4.35 ± 7.02

− 10.64 ± 3.67

0.001#

Δ MAP, mmHg

− 1.59 ± 9.29

− 1.19 ± 6.09

0.699#

Δ Heart rate, beat/minute

2.07 ± 14.14

0.80 ± 3.18

0.523#

Δ Total bilirubin, mg/dL

0.15 ± 0.89

0.12 ± 0.59

0.756#

Δ Total protein, g/dL

− 0.12 ± 0.49

− 0.28 ± 0.85

0.249

Δ Albumin, g/dL

− 0.01 ± 0.19

2.35 ± 11.56

0.65#

Δ AST, U/L

− 0.95 ± 24.65

0.80 ± 25.02

0.756

Δ ALT, U/L

− 2.34 ± 24.98

2.44 ± 12.10

0.358

Δ ALP, U/L

− 12.06 ± 114.57

− 31.12 ± 106.93

0.46

Δ GGT, U/L

− 1.72 ± 20.57

− 7.86 ± 72.38

0.486

Δ Urea, mg/dL

14.96 ± 23.84

3.72 ± 10.62

0.005#

Δ Creatinine, mg/dL

0.14 ± 0.35

0.06 ± 0.29

0.348#

Δ Sodium, mmol/L

−1.84 ± 17.39

− 2.72 ± 1.43

0.8

Δ Potassium, mmol/L

0.07 ± 0.69

− 0.14 ± 0.64

0.166

Δ MELD

0.79 ± 3.46

0.12 ± 1.59

0.145#

Δ PRA, pg/mL

281.95 ± 851.4

26.28 ± 30.2

0.102#

PRA percent increase

10.97 ± 30.77

12.57 ± 14.87

0.844#

  1. Δ indicates day 6 values to day 1 value
  2. MAP mean arterial pressure, PRA plasma renin activity
  3. #Mann–Whitney U test